ArticleVeterinary medicine and science2025
Extended Spectrum Beta-Lactamase Producing Escherichia coli in Pet Cats and Dogs in Central Peninsular Malaysia.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEpidemiological study of pets in Malaysia as reservoirs for antimicrobial resistant bacteria is unknown.
objectivesThis study aims to determine the extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from rectal swabs pet cats and dogs in the central region of Peninsular Malaysia. MATERIALS AND
methodsA cross-sectional study on physically healthy pet cats and dogs was conducted in the Klang Valley between 2019 and 2020. Rectal swabs were collected for ESBL-producing E. coli identification and detection. A questionnaire was used to collect pet data, and univariable and multivariable analysis was conducted to determine risk factors ESBL-producing E. coli detection.
resultsA total of 160 rectal swabs were collected from physically healthy pets in the Klang Valley, with 6.8% (n = 11) dogs and 3.8% (n = 6) cats were positive for ESBL-producing E. coli (10.6%). The highest resistance demonstrated by the ESBL isolates was towards ampicillin, cephalexin and cefotaxime (100%). Multiple-drug resistance of the ESBL-isolates was high, with 91.7% (n = 22) and 68.8% (n = 11) in dogs and cats. The most predominant ESBL genes was bla
conclusionESBL-producing E. coli in cats and dogs in Malaysia was determined at 10.6%, with dogs at a greater risk of carrying the bacteria. Co-resistance to more than three types of tested antibiotics for the ESBL-producing E. coli isolated was high. Pets act as reservoirs for antimicrobial resistance (AMR) and resistance genes that can be shared with human through interactions. Antimicrobial stewardship remains critical to safeguard not only antibiotics but also the health of pets and humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.